Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Alfacalcidol Supplementation to Respiratory Infection, Inflammatory Markers and CD4/CD8 Ratio of Indonesian Elderly

NCT03292744 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT03292744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03292744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Alfacalcidol Supplementation to Respiratory Infection, Inflammatory Markers and CD4/CD8 Ratio of Indonesian Elderly
Lead sponsor
Indonesia University
Phase
Phase 4
Overall status
Unknown status
Start date
January 10, 2017
Completion date
December 15, 2017
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly infection, frail elderly syndrome